Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.

Publication

Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.

Journal Paper/Review - May 17, 2020

Tsivgoulis Georgios, Katsanos Aristeidis H, Seiffge David Julian, Paciaroni Maurizio, Wilson David C, Koga Masatoshi, Macha Kosmas, Cappellari Manuel, Kallmünzer Bernd, Polymeris Alexandros A, Toyoda Kazunori, Caso Valeria, Werring David J, Engelter Stefan T, De Marchis Gian Marco, RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen, Verona registry collaborators

Citation

Tsivgoulis G, Katsanos A, Seiffge D, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M, Kallmünzer B, Polymeris A, Toyoda K, Caso V, Werring D, Engelter S, De Marchis G, RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen, Verona registry collaborators. Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation. Eur J Neurol 2020; 27:1612-1617.

Type

Journal Paper/Review (English)

Journal

Eur J Neurol 2020; 27

Publication Date

May 17, 2020

Issn Electronic

1468-1331

Pages

1612-1617

Brief description/objective

In this pooled analysis of seven multicentre cohorts potential differences were investigated in the incidence, characteristics and outcomes between intracranial haemorrhages (ICHs) associated with the use of non-vitamin K antagonist oral anticoagulants (NOAC-ICH) or with vitamin K antagonists (VKA-ICH) in ischaemic stroke patients after oral anticoagulant treatment initiation for atrial fibrillation (AF).